[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371149-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371149-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinicopathological-features-of-lynch-syndrome-pedigrees-with-msh2-c351ga-gene-variant","Clinicopathological features of Lynch syndrome pedigrees with MSH2 c.351G>A gene variant","","Lynch syndrome is an autosomal-dominant cancer predisposition disorder that elevates risk for multiple malignancies. This study aims to detect novel or rare pathogenic mismatch repair (MMR) variants linked to Lynch syndrome, with a focus on Chinese pedigrees. A four-generation Northeast China Han family (29 members) was evaluated, using Amsterdam II criteria and applying immunohistochemistry, MSI testing, whole-exome sequencing, and Sanger validation to define genotype-phenotype associations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinicopathological-features-of-lynch-syndrome-pedigrees-with-msh2-c351ga-gene-variant/371149/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinicopathological-features-of-lynch-syndrome-pedigrees-with-msh2-c351ga-gene-variant/371149.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study?","Question",{"text":63,"@type":64},"To identify novel or rare pathogenic MMR variants associated with Lynch syndrome, especially within Chinese pedigrees.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the Lynch syndrome diagnosis established for the family?",{"text":68,"@type":64},"Using the Amsterdam II clinical diagnosis criteria and then confirming molecular and pathological features with immunohistochemistry and MSI testing.",{"name":70,"@type":61,"acceptedAnswer":71},"Which genetic change was identified in the MSH2 gene?",{"text":72,"@type":64},"A nonsense variant, MSH2: c.351G>A (p.W117*), detected by whole-exome sequencing in affected individuals and verified by Sanger sequencing.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371149,1790468176,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","DOI: 10.1002/mgg3.2506  \nORIGINAL ARTICLE  \nClinicopathological features of Lynch syndrome pedigrees with MSH2 c.351G>A gene variant  \nShuai Zhang1 | Guanyu Fu2 | Gongping Sun2 | Yuanxin Tang2 | Jin Meng3 | Zhigang Wang3 | Rongjun Su1 | Wei Liu1 | Xiaoxia Li2   \n1Department of General Surgery, Yan'an people's Hospital, Shaanxi, China 2Department of General Surgery, The Fourth Affiliated Hospital,  \nChina Medical University, Shenyang, Liaoning, China  \n3Department of Fifth Treatment Areas of Anorectal Disease, Shenyang Coloproctology Hospital, Shenyang, Liaoning, China  \nCorrespondence  \nXiaoxia Li, Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, Liaoning Province 110032, China. [Email:](Email: xxli63@cmu.edu.cn)[ xxli63@cmu.edu.cn](Email: xxli63@cmu.edu.cn)  \nFunding information  \nPopulation and Health Applied Techniques Research Fund of Shenyang Municipal Technology Project,  \nGrant/Award Number: 18-014-4-19; Yan'an Science and Technology Plan Project, Grant/Award Number:  \nSL2019ZCSY-102; basic scientific research projects of universities in Liaoning Province, Grant/Award Number: LFWK201712; basic scientific research projects in Shanxi Province, Grant/Award Number: 2020JM-704  \nAbstract  \nBackground: Lynch syndrome (LS) is an autosomal-dominant disorder that increases the risk of many cancers. To identify novel or rare pathogenic variants of MMR genes associated with LS, especially in Chinese pedigrees.  \nMethods: One four-generation Chinese Han family from northeast China with 29 members was enrolled. Clinical diagnosis of LS was established in this family, according to Amsterdam II. The proband and some relatives of the family were subjected to immunohistochemical analysis of MMR protein, microsatellite instability (MSI) testing, whole-exome sequencing, and Sanger sequencing. Results: Nine patients with 19 primary cancers were found in this family, with a wide spectrum of synchronous and metachronous cancers, including digestive, reproductive, respiratory, urinary, and other systems. In addition, one member of this family is found to have both thyroid and lung cancers, which have been reported only once in LS patients before but have not been considered extracolonic in the LS spectrum. The immunohistochemical analysis of the mother of the proband showed loss of MSH2 and MSH6 protein, and consistently, high microsatellite instability (MSI-H) was confirmed in LS patients. Furthermore, whole-exome sequencing identified a nonsense variant in MSH2, MSH2:NM_ 000251:c.351G >A(p.W117*), in all three tested LS patients (II-1, III- 1, and III-4), but not in healthy relatives IV-1 in this family. This result is further verified by Sanger sequencing.  \nConclusion: Uncover a rare nonsense variant in MSH2 gene, which contributes to LS ofthis family. The clinicopathological characteristics of LS in this family include common simultaneous or heterogeneous multiple primary cancers, a broad tumor spectrum, and a younger age with the continuation of genetic algebra.  \nKEYWORDS  \nChinese family, clinicopathological features, Lynch syndrome, MSH2 gene variant  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2024 The Author(s). Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC.  \nMol Genet Genomic Med. 2025;13:e2506 .  \n[https://doi.org/10.1002/mgg3.2506](https://doi.org/10.1002/mgg3.2506)  \n[wileyonlinelibrary.com/journal/mgg3](wileyonlinelibrary.com/journal/mgg3)  \n1 of 12  \n1 | INTRODUCTION  \nLynch syndrome is an autosomal dominant cancer susceptibility syndrome characterized by a wide spectrum of synchronous and metachronous cancers, including colorectal cancer (CRC), and cancers of the endometrium, stomach, ovary, ureter or renal p","cbCaijpSIBM2OYvx","https://ap.wps.com/l/cbCaijpSIBM2OYvx","pdf",2793618,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Lynch syndrome cancer spectrum and genetic basis\n## MMR pathway, MSI, and significance of variant discovery","[{\"question\":\"What is the main purpose of the study?\",\"answer\":\"To identify novel or rare pathogenic MMR variants associated with Lynch syndrome, especially within Chinese pedigrees.\"},{\"question\":\"How was the Lynch syndrome diagnosis established for the family?\",\"answer\":\"Using the Amsterdam II clinical diagnosis criteria and then confirming molecular and pathological features with immunohistochemistry and MSI testing.\"},{\"question\":\"Which genetic change was identified in the MSH2 gene?\",\"answer\":\"A nonsense variant, MSH2: c.351G\\u003eA (p.W117*), detected by whole-exome sequencing in affected individuals and verified by Sanger sequencing.\"}]","Clinicopathological features of Lynch syndrome pedigrees with MSH2 c.351G>A gene variant | PDF",1790191402,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd37ba88988ae4ffdda9dc32bb41337c.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a154f91c78e17398df7c4e4d648bd71b.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de4029f5f1987eccb602fcda4f57c962.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c66ad66acb76569b197e8f27c173d4e4.webp",980,1287]